![](https://cdn.sanity.io/images/0vv8moc6/onclive/c6d0d4db052439426721732df3be7b4872f443af-262x145.jpg?fit=crop&auto=format)
Dr Colman on Outcomes With Eflornithine in Grade 3 Anaplastic Astrocytoma
“When the current grade 3 astrocytoma population—the IDH-mutant, CDKN2-intact population—was analyzed, there was a very clinically significant and statistically significant benefit in terms of OS and PFS [with eflornithine plus lomustine vs lomustine alone …